Singapore markets closed

CRMD Sep 2024 3.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.00000.0000 (0.00%)
At close: 11:20AM EDT
Full screen
Previous close3.0000
Open2.5500
Bid2.3000
Ask3.2000
Strike3.00
Expiry date2024-09-20
Day's range2.5500 - 3.0000
Contract rangeN/A
Volume5
Open interest303
  • GlobeNewswire

    CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider

    BERKELEY HEIGHTS, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a multi-year commercial supply contract with a top tier midsized dialysis provider for the supply of DefenCath® (taurolidine and heparin). CorMedix received NDA approval of DefenCath® under the Limited Population Pathway for Antibacterial and Antifungal D

  • Insider Monkey

    CorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call Transcript

    CorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call Transcript May 11, 2024 CorMedix Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the CorMedix First Quarter 2024 Earnings Conference Call [Operator Instructions]. Today’s conference call is […]

  • GlobeNewswire

    CorMedix Inc. to Participate in Two Upcoming Investor Conferences

    BERKELEY HEIGHTS, N.J., May 10, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that management will be participating in fireside chats and investor meetings at both the JMP Securities Life Sciences Conference being held in New York on May 13 – 14, 2024 and the 2024 RBC Capital Markets Global Healthcare Conference being held in New York o